Cargando…
Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study
OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is recognized as a common cause of chronic liver disease worldwide. Its association with type 2 diabetes mellitus (T2DM) is known to increase the risk of degenerative complications of diabetes and the likelihood of developing severe hepatic injuri...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SBDR - Society for Biomedical Diabetes Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652707/ https://www.ncbi.nlm.nih.gov/pubmed/36309775 http://dx.doi.org/10.1900/RDS.2022.18.140 |
_version_ | 1784828533130919936 |
---|---|
author | Assarrar, Imane Messaoudi, Najoua Ongoth, Farel Elilie Mawa Abdellaoui, Wahiba Malki, Abdessamad Rouf, Siham Abda, Naima Ismaili, Zahi Latrech, Hanane |
author_facet | Assarrar, Imane Messaoudi, Najoua Ongoth, Farel Elilie Mawa Abdellaoui, Wahiba Malki, Abdessamad Rouf, Siham Abda, Naima Ismaili, Zahi Latrech, Hanane |
author_sort | Assarrar, Imane |
collection | PubMed |
description | OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is recognized as a common cause of chronic liver disease worldwide. Its association with type 2 diabetes mellitus (T2DM) is known to increase the risk of degenerative complications of diabetes and the likelihood of developing severe hepatic injuries. The objective of this study was to assess the prevalence of NAFLD and to describe the characteristics of its association with T2DM. METHODS: This was a descriptive analytical study, involving patients with T2DM with no history of alcohol consumption, viral hepatitis, hepatotoxic medications, or other chronic liver diseases. The patients underwent an investigation of NAFLD including abdominal ultrasound, non-invasive biomarkers of liver fibrosis, elastography and ultrasound-guided liver biopsy. RESULTS: We collected data from 180 patients with a mean age of 59.3 ± 10.9 years with strong female predominance. The mean duration of diabetes progression was 9.2 ± 7.3 years. Hepatic sonography showed signs of NAFLD in 45.6% of cases. Non-invasive hepatic biomarkers indicated significant fibrosis in 18.3% of cases. Overall, 21% of patients underwent an elastography evaluation, revealing severe fibrosis or cirrhosis in 15.4% of patients. The diagnosis of NASH (Non-alcoholic steatohepatitis) was confirmed histologically in 3 patients. The overall prevalence of NAFLD was 45.6%. Patients with NAFLD had a statistically significant incidence of obesity, metabolic syndrome, hypertension, dyslipidemia, macrovascular complications, and hypertriglyceridemia (p < 0.05). CONCLUSIONS: The combination of NAFLD and T2DM is often found in patients with obesity or metabolic syndrome. The presence of NAFLD can be responsible for increased morbidity and important cardiovascular risks in patients with T2DM. |
format | Online Article Text |
id | pubmed-9652707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SBDR - Society for Biomedical Diabetes Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-96527072022-11-22 Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study Assarrar, Imane Messaoudi, Najoua Ongoth, Farel Elilie Mawa Abdellaoui, Wahiba Malki, Abdessamad Rouf, Siham Abda, Naima Ismaili, Zahi Latrech, Hanane Rev Diabet Stud Research OBJECTIVE: Non-alcoholic fatty liver disease (NAFLD) is recognized as a common cause of chronic liver disease worldwide. Its association with type 2 diabetes mellitus (T2DM) is known to increase the risk of degenerative complications of diabetes and the likelihood of developing severe hepatic injuries. The objective of this study was to assess the prevalence of NAFLD and to describe the characteristics of its association with T2DM. METHODS: This was a descriptive analytical study, involving patients with T2DM with no history of alcohol consumption, viral hepatitis, hepatotoxic medications, or other chronic liver diseases. The patients underwent an investigation of NAFLD including abdominal ultrasound, non-invasive biomarkers of liver fibrosis, elastography and ultrasound-guided liver biopsy. RESULTS: We collected data from 180 patients with a mean age of 59.3 ± 10.9 years with strong female predominance. The mean duration of diabetes progression was 9.2 ± 7.3 years. Hepatic sonography showed signs of NAFLD in 45.6% of cases. Non-invasive hepatic biomarkers indicated significant fibrosis in 18.3% of cases. Overall, 21% of patients underwent an elastography evaluation, revealing severe fibrosis or cirrhosis in 15.4% of patients. The diagnosis of NASH (Non-alcoholic steatohepatitis) was confirmed histologically in 3 patients. The overall prevalence of NAFLD was 45.6%. Patients with NAFLD had a statistically significant incidence of obesity, metabolic syndrome, hypertension, dyslipidemia, macrovascular complications, and hypertriglyceridemia (p < 0.05). CONCLUSIONS: The combination of NAFLD and T2DM is often found in patients with obesity or metabolic syndrome. The presence of NAFLD can be responsible for increased morbidity and important cardiovascular risks in patients with T2DM. SBDR - Society for Biomedical Diabetes Research 2022-09-30 /pmc/articles/PMC9652707/ /pubmed/36309775 http://dx.doi.org/10.1900/RDS.2022.18.140 Text en Copyright © by Lab & Life Press https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 Unported (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Research Assarrar, Imane Messaoudi, Najoua Ongoth, Farel Elilie Mawa Abdellaoui, Wahiba Malki, Abdessamad Rouf, Siham Abda, Naima Ismaili, Zahi Latrech, Hanane Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study |
title | Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study |
title_full | Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study |
title_fullStr | Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study |
title_full_unstemmed | Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study |
title_short | Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study |
title_sort | prevalence and specific manifestations of non-alcoholic fatty liver disease (nafld) and diabetes mellitus type 2 association in a moroccan population: a cross-sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652707/ https://www.ncbi.nlm.nih.gov/pubmed/36309775 http://dx.doi.org/10.1900/RDS.2022.18.140 |
work_keys_str_mv | AT assarrarimane prevalenceandspecificmanifestationsofnonalcoholicfattyliverdiseasenafldanddiabetesmellitustype2associationinamoroccanpopulationacrosssectionalstudy AT messaoudinajoua prevalenceandspecificmanifestationsofnonalcoholicfattyliverdiseasenafldanddiabetesmellitustype2associationinamoroccanpopulationacrosssectionalstudy AT ongothfareleliliemawa prevalenceandspecificmanifestationsofnonalcoholicfattyliverdiseasenafldanddiabetesmellitustype2associationinamoroccanpopulationacrosssectionalstudy AT abdellaouiwahiba prevalenceandspecificmanifestationsofnonalcoholicfattyliverdiseasenafldanddiabetesmellitustype2associationinamoroccanpopulationacrosssectionalstudy AT malkiabdessamad prevalenceandspecificmanifestationsofnonalcoholicfattyliverdiseasenafldanddiabetesmellitustype2associationinamoroccanpopulationacrosssectionalstudy AT roufsiham prevalenceandspecificmanifestationsofnonalcoholicfattyliverdiseasenafldanddiabetesmellitustype2associationinamoroccanpopulationacrosssectionalstudy AT abdanaima prevalenceandspecificmanifestationsofnonalcoholicfattyliverdiseasenafldanddiabetesmellitustype2associationinamoroccanpopulationacrosssectionalstudy AT ismailizahi prevalenceandspecificmanifestationsofnonalcoholicfattyliverdiseasenafldanddiabetesmellitustype2associationinamoroccanpopulationacrosssectionalstudy AT latrechhanane prevalenceandspecificmanifestationsofnonalcoholicfattyliverdiseasenafldanddiabetesmellitustype2associationinamoroccanpopulationacrosssectionalstudy |